University of the Witwatersrand, South Africa and University of Malawi College of Medicine
Chikondi is studying an MSc (MMED) in Vaccinology student under
African Leadership In Vaccinology Expertise (ALIVE) program scholarship. Her research interests are in TB vaccine development and testing, TB immunology and TB vaccine efficacy and safety and is currently working on a randomized, open-label controlled trial investigating the benefits of using response to broad spectrum antibiotics as an exclusion diagnostic for tuberculosis (TB) in primary care adult patients versus risk of antimicrobial resistance (AMR).